Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
- PMID: 7584144
- DOI: 10.1016/1074-7613(95)90125-6
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
Abstract
The B7-CD28/CTLA-4 costimulatory pathway can provide a signal pivotal for T cell activation. Signaling through this pathway is complex due to the presence of two B7 family members, B7-1 and B7-2, and two counterreceptors, CD28 and CTLA-4. Studies with anti-CTLA-4 monoclonal antibodies have suggested both positive and negative roles for CTLA-4 in T cell activation. To elucidate the in vivo function of CTLA-4, we generated CTLA-4-deficient mice. These mice rapidly develop lymphoproliferative disease with multiorgan lymphocytic infiltration and tissue destruction, with particularly severe myocarditis and pancreatitis, and die by 3-4 weeks of age. The phenotype of the CTLA-4-deficient mouse strain is supported by studies that have suggested a negative role for CTLA-4 in T cell activation. The severe phenotype of mice lacking CTLA-4 implies a critical role for CTLA-4 in down-regulating T cell activation and maintaining immunologic homeostasis. In the absence of CTLA-4, peripheral T cells are activated, can spontaneously proliferate, and may mediate lethal tissue injury.
Similar articles
-
Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.J Immunol. 1999 May 15;162(10):5784-91. J Immunol. 1999. PMID: 10229811
-
CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice.J Immunol. 1997 Jun 1;158(11):5091-4. J Immunol. 1997. PMID: 9164923
-
B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).J Exp Med. 1999 Jan 18;189(2):435-40. doi: 10.1084/jem.189.2.435. J Exp Med. 1999. PMID: 9892625 Free PMC article.
-
The complexity of the B7-CD28/CTLA-4 costimulatory pathway.Agents Actions Suppl. 1998;49:33-43. doi: 10.1007/978-3-0348-8857-8_6. Agents Actions Suppl. 1998. PMID: 9426826 Review.
-
Expression and functional significance of CTLA-4, a negative regulator of T cell activation.Arch Immunol Ther Exp (Warsz). 2001;49(1):39-46. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11266089 Review.
Cited by
-
CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner.Nat Commun. 2024 Nov 4;15(1):9520. doi: 10.1038/s41467-024-51719-6. Nat Commun. 2024. PMID: 39496592 Free PMC article.
-
Application of novel CAR technologies to improve treatment of autoimmune disease.Front Immunol. 2024 Oct 9;15:1465191. doi: 10.3389/fimmu.2024.1465191. eCollection 2024. Front Immunol. 2024. PMID: 39445021 Free PMC article. Review.
-
Revolutionizing CAR T-Cell Therapies: Innovations in Genetic Engineering and Manufacturing to Enhance Efficacy and Accessibility.Int J Mol Sci. 2024 Sep 26;25(19):10365. doi: 10.3390/ijms251910365. Int J Mol Sci. 2024. PMID: 39408696 Free PMC article. Review.
-
Immunotherapy for glioblastoma: current state, challenges, and future perspectives.Cell Mol Immunol. 2024 Oct 15. doi: 10.1038/s41423-024-01226-x. Online ahead of print. Cell Mol Immunol. 2024. PMID: 39406966 Review.
-
Immune Checkpoints and Cellular Landscape of the Tumor Microenvironment in Non-Melanoma Skin Cancer (NMSC).Cells. 2024 Sep 26;13(19):1615. doi: 10.3390/cells13191615. Cells. 2024. PMID: 39404378 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases